Ewing sarcoma carries few mutations other than the pathognomonic EWS/Fli1 gene fusion [4–6], and previous studies have demonstrated that while these tumors do not have genomic heterogeneity, there is transcriptional heterogeneity observed in cell lines and xenografts [7, 8]. The gene discussed is FLI1; the disease is Ewing sarcoma.